Results 121 to 130 of about 1,432,292 (149)

Identification of the second major allergen of Japanese cedar pollen

Allergy: European Journal of Allergy and Clinical Immunology, 1990
We isolated and characterized the second major allergen (Cry j II) from Japanese cedar pollen. We found that most patients with this pollinosis had IgE antibody to this protein in addition to IgE antibody to Cry j I; however, some sera reacted only with Cry j I or Cry j IL IgE‐ELISA inhibition studies revealed that Cry j I and Cry j II had no cross ...
M, Sakaguchi, S, Inouye, M, Taniai, S, Ando, M, Usui, T, Matuhasi   +5 more
exaly   +3 more sources

Induction of oral tolerance to Japanese cedar pollen

Archives of Pharmacal Research, 2001
Oral tolerance is thought to play a role in preventing allergic responses and immune-mediated diseases. An improved mouse model of the oral tolerance to Japanese cedar pollen (JCP) as antigen was developed in order to detect induction of the tolerance, and the immunological characteristics of this model were also elucidated.
J H, Kim, Y J, Mun, S H, Ahn, J S, Park, W H, Woo   +4 more
openaire   +2 more sources

Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis

Clinical Immunology, 2020
Sublingual immunotherapy (SLIT) with Japanese cedar (JCe) pollinosis was expected to be effective for Japanese cypress (JCy) pollinosis. However, only a half of JCy pollinosis patients clinically improved. Therefore, we examined the immunological effect of SLIT for JCy pollinosis.
Hirotaka, Kikuoka, Hideaki, Kouzaki, Koji, Matsumoto, Hiroyuki, Arai, Sayuri, Yamamoto, Ichiro, Tojima, Shino, Shimizu, Hiromi, Miyashita, Yukiko, Ogawa, Toshihiro, Osada, Mitsuhiro, Okano, Atsushi, Yuta, Takeshi, Shimizu   +12 more
openaire   +2 more sources

Japanese cedar/Japanese cypress pollen‐dispersion information and the initial therapy

Clinical & Experimental Allergy Reviews, 2010
SummaryThe original initial therapy against pollinosis was introduced to the clinical setting in Japan in the 1980s, led by the launch of anti‐allergic drugs that were expected to exert prophylactic effects. The purpose of the therapy was to control the typical pollinosis seen in Japan: that occurs due to Japanese cedar/Japanese cypress pollens.
openaire   +1 more source

[Pollen information of airborne Japanese cedar pollen using a simulation method].

Arerugi = [Allergy], 1996
We have developed a simulation method of airborne Cryptomeria japonica pollen distribution on a map displayed visually on a TV screen. Each patient can be available the information where the place he or she lives. The pollen season in 1995, we served the information about airborne pollen distribution on a map and C. japonica flowering areas on a map to
Y, Takahashi, S, Kawashima, S, Aikawa
openaire   +1 more source

Gibberellin‐regulated protein sensitization in Japanese cedar (Cryptomeria japonica) pollen allergic Japanese cohorts

Allergy: European Journal of Allergy and Clinical Immunology, 2021
Tomoyasu Aizawa, Pascal Poncet, Motohiro Ebisawa   +2 more
exaly  

[Regional differences in the prevalence of Japanese cedar-pollen allergy].

Arerugi = [Allergy], 2010
According to the 2008 survey conducted by Baba et al., the average prevalence of Japanese cedar-pollen allergy is 26.5% in Japan, although there are great regional differences in the prevalence of this disease. In this study, we investigated the causes of its regional differences.Regional differences in the 2008 prevalence of cedar-pollen allergy in 47
Koji, Murayama, Kotaro, Baba, Kimihiro, Okubo   +2 more
openaire   +1 more source

Japanese cedar pollen allergy immunotherapy

Reactions Weekly, 2019
openaire   +1 more source

Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial

Allergology International, 2021
Yoshitaka Okamoto, Kimihiro Okubo, Yasuyuki Nomura   +2 more
exaly  

Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen

Journal of Bioscience and Bioengineering, 2012
Yuki Takaoka, Tsunehiro Aki, Seiji Kawamoto   +2 more
exaly